Youzhiyou Biopharmaceutical

YZY Biopharma is a biotechnology company specializing in the development of bispecific antibodies aimed at enhancing T cell infiltration and antitumor activity, particularly for triple-negative breast cancer. Operating in the biopharmaceutical sector, YZY Biopharma serves clients in the healthcare and medical research industries, focusing on innovative immunotherapy solutions. The company's business model revolves around the research, development, and commercialization of advanced therapeutic antibodies. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary biopharmaceutical products. YZY Biopharma's market includes both China and the United States, where it leverages cutting-edge technology and scientific research to address unmet medical needs in oncology and immunotherapy. Keywords: bispecific antibodies, T cell infiltration, antitumor activity, immunotherapy, triple-negative breast cancer, biotechnology, healthcare, medical research, oncology, biopharmaceutical.